Antibodies to Chlamydia trachomatis and risk for tubal pregnancy

Mark D. Walters, Carlton A. Eddy, Ronald S. Gibbs, Julius Schachter, Alan E.C. Holden, Carl J. Pauerstein

Research output: Contribution to journalArticle

54 Scopus citations

Abstract

We performed a case-control study of the effect of exposure to Chlamydia trachomatis on the risk for tubal pregnancy. Sixty women with tubal pregnancies and 60 matched control women with normal second-trimester intrauterine pregnancies were studied. Cases were more likely than controls to have detectable antichlamydial IgG antibodies (82% versus 58%, p < 0.01) and their mean titers were higher. The prevalence of IgM antibody seropositivity was not different between cases and controls (20% versus 12%, not significant). Compared with women with IgG antibody titers of ⩽1:8 the relative risk for tubal pregnancy for women with titers ⩾1:128 was 6.6 (95% confidence interval, 2.0 to 21.6). Among women with tubal pregnancies, antichlamydial antibody titers of ⩾1:128 were significantly associated with pelvic adhesions and inflammatory tubal mucosal damage. Only 17.6% of women with detectable antichlamydial antibody or inflammatory tubal damage reported a history of pelvic inflammatory disease or gonorrhea.

Original languageEnglish (US)
Pages (from-to)942-946
Number of pages5
JournalAmerican Journal of Obstetrics and Gynecology
Volume159
Issue number4
DOIs
StatePublished - Jan 1 1988

Keywords

  • Chlamydia trachomatis
  • Ectopic pregnancy

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Antibodies to Chlamydia trachomatis and risk for tubal pregnancy'. Together they form a unique fingerprint.

  • Cite this

    Walters, M. D., Eddy, C. A., Gibbs, R. S., Schachter, J., Holden, A. E. C., & Pauerstein, C. J. (1988). Antibodies to Chlamydia trachomatis and risk for tubal pregnancy. American Journal of Obstetrics and Gynecology, 159(4), 942-946. https://doi.org/10.1016/S0002-9378(88)80177-7